Directorio de personas
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grado: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicaciones

  • Caus, M; Bozic, M; Fernandez, E; Valdivielso, JM

    ABSENCE OF VDR SOLELY IN VSMCS IMPEDES ARTERIAL CALCIFICATION IN CKD THROUGH TARGETING MIR-145A AND MIR-155

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 190-190. .

  • Cambray, S; Galimudi, RK; Bozic, M; Bermudez-Lopez, M; Rodriguez, I; Valdivielso, JM

    A The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort

    Journal of Clinical Medicine 8 -. .

    [doi:10.3390/jcm8050592]

  • Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project

    Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project

    Journal of Atherosclerosis and Thrombosis 26 879-889. .

    [doi:10.5551/jat.47498]

  • Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM

    Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort

    Frontiers in Genetics 10 118-118. .

    [doi:10.3389/fgene.2019.00118]

  • Sarafidis, P; Ferro, CJ; Morales, E; Ortiz, A; Malyszko, J; Hojs, R; Khazim, K; Ekart, R; Valdivielso, J; Fouque, D; London, GM; Massy, Z; Ruggenenti, P; Porrini, E; Wiecek, A; Zoccali, C; Mallamaci, F; Hornum, M

    SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 208-230. .

    [doi:10.1093/ndt/gfy407]

  • Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C

    Lipid management in patients with chronic kidney disease (vol 14, pg 727, 2018)

    NATURE REVIEWS NEPHROLOGY 15 121-121. .

    [doi:10.1038/s41581-018-0099-y]

  • Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M; CKD Prognosis Consortium (CKD-PC)

    Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

    BMJ-BRITISH MEDICAL JOURNAL 364 -. .

    [doi:10.1136/bmj.k5301]

  • Valdivielso, JM; Jacobs-Cacha, C; Soler, MJ

    Sex hormones and their influence on chronic kidney disease

    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 28 1-9. .

    [doi:10.1097/MNH.0000000000000463]

  • Perez-Morales, RE; del Pino, M; Valdivielso, JM; Ortiz, A; Mora-Fernandez, C; Navarro-Gonzalez, JF

    Inflammation in Diabetic Kidney Disease

    Nephron 143 12-16. .

    [doi:10.1159/000493278]

  • Morgado-Pascual, JL; Marchant, V; Rodrigues-Diez, R; Dolade, N; Suarez-Alvarez, B; Kerr, B; Valdivielso, JM; Ruiz-Ortega, M; Rayego-Mateos, S

    Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology

    Mediators of Inflammation 2018 2931049-2931049. .

    [doi:10.1155/2018/2931049]

  • Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.

    Peritoneal Dialysis Is an Independent Factor Associated to Lower lntima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease

    Frontiers in physiology 9 1743-1743. .

    [doi:10.3389/fphys.2018.01743]

  • Ferro, CJ; Mark, PB; Kanbay, M; Sarafidis, P; Heine, GH; Rossignol, P; Massy, ZA; Mallamaci, F; Valdivielso, JM; Malyszko, J; Verhaar, MC; Ekart, R; Vanholder, R; London, G; Ortiz, A; Zoccali, C

    Lipid management in patients with chronic kidney disease

    NATURE REVIEWS NEPHROLOGY 14 727-749. .

    [doi:10.1038/s41581-018-0072-9]

Proyectos

  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.